Tria Beauty, a Dublin, CA maker of light-based therapeutic beauty devices, has received over-the-counter (OTC) clearance from the U.S. Food and Drug Administration (FDA) for a hand-held blue light device designed for at-home treatment of mild to moderate inflammatory acne.

"This new platform validates Tria Beauty's heritage of harnessing technology previously available only in a professional setting so that it is safe and effective for daily at-home use," said Robert Grove, chief technology officer of TRIA Beauty. "We believe this technology is far superior to any blue light device currently on the market and are confident consumers will agree."

The company contends it has developed a blue light technology that is 10 times more powerful than other OTC blue light devices. The proprietary design allows the Tria blue light to deliver an effective dose of blue light in much shorter treatment times, and to achieve faster clearance of breakouts. In multiple clinical studies conducted by leading dermatologists, the Tria blue light technology, used two to three minutes, twice a day, cleared breakouts as quickly and effectively as professional blue light treatments as well as the leading prescription drug therapy, and more effectively than any other OTC option, the company said.

"Our new FDA-cleared technology paves the way for a brand new proposition in the skin care category which will ultimately redefine clear, calm and healthy-looking skin," said Kevin Appelbaum, chief executive officer of Tria Beauty.